155 related articles for article (PubMed ID: 11069722)
1. Prostaglandins regulate melanoma-induced cytokine production in macrophages.
Eisengart CA; Mestre JR; Naama HA; Mackrell PJ; Rivadeneira DE; Murphy EM; Stapleton PP; Daly JM
Cell Immunol; 2000 Sep; 204(2):143-9. PubMed ID: 11069722
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of IL-6, TNF-alpha, and cyclooxygenase-2 protein expression by prostaglandin E2-induced IL-10 in bone marrow-derived dendritic cells.
Harizi H; Norbert G
Cell Immunol; 2004 Apr; 228(2):99-109. PubMed ID: 15219461
[TBL] [Abstract][Full Text] [Related]
3. NS-398 treatment after trauma modifies NF-kappaB activation and improves survival.
Mack Strong VE; Mackrell PJ; Concannon EM; Mestre JR; Smyth GP; Schaefer PA; Stapleton PP; Daly JM
J Surg Res; 2001 Jun; 98(1):40-6. PubMed ID: 11368536
[TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide modulates cyclooxygenase-2 transcriptionally and posttranscriptionally in human macrophages independently from endogenous IL-1 beta and TNF-alpha.
Barrios-Rodiles M; Tiraloche G; Chadee K
J Immunol; 1999 Jul; 163(2):963-9. PubMed ID: 10395693
[TBL] [Abstract][Full Text] [Related]
5. Exogenous but not endogenous prostanoids regulate cytokine secretion from murine bone marrow dendritic cells: EP2, DP, and IP but not EP1, EP3, and FP prostanoid receptors are involved.
Józefowski S; Bobek M; Marcinkiewicz J
Int Immunopharmacol; 2003 Jun; 3(6):865-78. PubMed ID: 12781703
[TBL] [Abstract][Full Text] [Related]
6. Melanoma inhibits macrophage activation by suppressing toll-like receptor 4 signaling.
Clarke JH; Cha JY; Walsh MD; Gamboni-Robertson F; Banerjee A; Reznikov LL; Dinarello CA; Harken AH; McCarter MD
J Am Coll Surg; 2005 Sep; 201(3):418-25. PubMed ID: 16125076
[TBL] [Abstract][Full Text] [Related]
7. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
Minter HA; Eveson JW; Huntley S; Elder DJ; Hague A
Clin Cancer Res; 2003 May; 9(5):1885-97. PubMed ID: 12738747
[TBL] [Abstract][Full Text] [Related]
8. Suppressive effect of selective cyclooxygenase-2 inhibitor on cytokine release in human neutrophils.
Kimura T; Iwase M; Kondo G; Watanabe H; Ohashi M; Ito D; Nagumo M
Int Immunopharmacol; 2003 Oct; 3(10-11):1519-28. PubMed ID: 12946449
[TBL] [Abstract][Full Text] [Related]
9. Increase of cyclooxygenase-2 expression by interleukin 15 in rheumatoid synoviocytes.
Min SY; Hwang SY; Jung YO; Jeong J; Park SH; Cho CS; Kim HY; Kim WU
J Rheumatol; 2004 May; 31(5):875-83. PubMed ID: 15124245
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2 inhibits transforming growth factor beta 1-mediated induction of collagen alpha 1(I) in hepatic stellate cells.
Hui AY; Dannenberg AJ; Sung JJ; Subbaramaiah K; Du B; Olinga P; Friedman SL
J Hepatol; 2004 Aug; 41(2):251-8. PubMed ID: 15288474
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha induces cyclooxygenase-2 expression and prostaglandin release in brain microvessel endothelial cells.
Mark KS; Trickler WJ; Miller DW
J Pharmacol Exp Ther; 2001 Jun; 297(3):1051-8. PubMed ID: 11356928
[TBL] [Abstract][Full Text] [Related]
12. Agonist-specific regulation of monocyte chemoattractant protein-1 expression by cyclooxygenase metabolites in hepatic stellate cells.
Efsen E; Bonacchi A; Pastacaldi S; Valente AJ; Wenzel UO; Tosti-Guerra C; Pinzani M; Laffi G; Abboud HE; Gentilini P; Marra F
Hepatology; 2001 Mar; 33(3):713-21. PubMed ID: 11230753
[TBL] [Abstract][Full Text] [Related]
13. Effects of TGF-beta, TNF-alpha, IL-beta and IL-6 alone or in combination, and tyrosine kinase inhibitor on cyclooxygenase expression, prostaglandin E2 production and bone resorption in mouse calvarial bone cells.
Park YG; Kang SK; Kim WJ; Lee YC; Kim CH
Int J Biochem Cell Biol; 2004 Nov; 36(11):2270-80. PubMed ID: 15313472
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor alpha and interleukin-1beta stimulate the expression of cyclooxygenase II but do not alter prostaglandin E2 receptor mRNA levels in cultured dorsal root ganglia cells.
Fehrenbacher JC; Burkey TH; Nicol GD; Vasko MR
Pain; 2005 Jan; 113(1-2):113-22. PubMed ID: 15621371
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory effect of two isoforms of COX in H. pylori-induced gastritis in mice: possible involvement of PGE2.
Tanigawa T; Watanabe T; Hamaguchi M; Sasaki E; Tominaga K; Fujiwara Y; Oshitani N; Matsumoto T; Higuchi K; Arakawa T
Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G148-56. PubMed ID: 12958020
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent immunomodulatory effects of acetylsalicylic acid and indomethacin in human whole blood: potential role of cyclooxygenase-2 inhibition.
Härtel C; von Puttkamer J; Gallner F; Strunk T; Schultz C
Scand J Immunol; 2004 Oct; 60(4):412-20. PubMed ID: 15379866
[TBL] [Abstract][Full Text] [Related]
17. Expression of cyclooxygenase 2 in human malignant melanoma.
Denkert C; Köbel M; Berger S; Siegert A; Leclere A; Trefzer U; Hauptmann S
Cancer Res; 2001 Jan; 61(1):303-8. PubMed ID: 11196178
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cells issued in vitro from bone marrow produce PGE(2) that contributes to the immunomodulation induced by antigen-presenting cells.
Harizi H; Juzan M; Grosset C; Rashedi M; Gualde N
Cell Immunol; 2001 Apr; 209(1):19-28. PubMed ID: 11414733
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition.
Totzke G; Schulze-Osthoff K; Jänicke RU
Oncogene; 2003 Sep; 22(39):8021-30. PubMed ID: 12970750
[TBL] [Abstract][Full Text] [Related]
20. Bupivacaine inhibits COX-2 expression, PGE2, and cytokine production in endotoxin-activated macrophages.
Huang YH; Tsai PS; Huang CJ
Acta Anaesthesiol Scand; 2008 Apr; 52(4):530-5. PubMed ID: 18339158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
